ニューロンのニコチン受容体α4β2の2つのステキオメトリーにおけるいくつかのアゴニスト間の結合の変動
Ximena Da Silva Tavares1, Angela P Blum, Darren T Nakamura
1Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, USA.
Journal of the American Chemical Society
|June 22, 2012
まとめ
ニコチンと禁煙薬を含む4つのアゴニストは,ニコチンアセチルコリン受容体 (nAChR) との結合相互作用について研究されました. 水素結合の変動は,薬剤の有効性と受容体ステキオメトリの選択性を説明する.
科学分野:
- バイオケミストリー バイオケミストリー
- 薬理学 薬理学とは
- 神経科学は神経科学である.
背景:
- α4β2ニコチンアセチルコリン受容体 (nAChR) は,アセチルコリン (ACh),ニコチン,バレニクリン,シチシンを含む様々なアゴニストの主要な標的である.
- 薬物受容体結合相互作用を理解することは,効果的な治療法,特に禁煙のための治療法の開発に不可欠です.
- 以前の研究では,不自然なアミノ酸変異を利用して,nAChR内の重要な結合部位を特定しました.
研究 の 目的:
- 4つのアゴニスト (ACh,ニコチン,バレニクリン,サイトシン) の結合相互作用を,α4β2 nAChRの異なるステキオメトリー (2:3 と 3:2) で調べる.
- 薬物結合におけるカチオン-πと水素結合相互作用の役割を明らかにする.
- サイチシンの観察されたステキオメトリー選択性を合理化するために.
主な方法:
- 非自然のアミノ酸変異は,nAChRの特定の結合相互作用を調査するために使用されました.
- ACh,ニコチン,バレニクリン,シチシンの結合は,α4β2 nAChRの2:3および3:2ステキオメトリーで評価された.
- 分析は,カチオン-π相互作用と,受容体のタンパク質の骨格との水素結合パターンに焦点を当てた.
主要な成果:
- 試験された4つのアゴニストはすべて,nAChR.nAChRのTrpBとカチオン-π相互作用を形成しています.
- ほとんどのアゴニストは,背骨のカーボニルと水素結合を形成し,ACHとニコチンは水素結合受容体として作用する.
- ヴァレニクリンは,背骨NHへの水素結合受容体として作用せず,シチシンは独特の水素結合を示し,そのステキオメトリー選択性を説明します.
結論:
- この研究では,α4β2 nAChRでACH,ニコチン,バレニクリン,サイトシンに対する明確な結合相互作用プロファイルが明らかになりました.
- 水素結合パターンは,これらの化合物の有効性や選択性に大きな影響を与えます.
- これらの発見は,薬物作用を理解し,nAChRを標的とする新薬の設計を導くための分子基盤を提供します.
関連する概念動画
Cholinergic Receptors: Nicotinic
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Drug-Receptor Interaction: Agonist
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...
Adrenergic Receptors: ɑ Subtype
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...


